Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report)’s share price traded down 2.9% during trading on Thursday . The stock traded as low as $20.20 and last traded at $20.20. 411 shares changed hands during trading, a decline of 81% from the average session volume of 2,218 shares. The stock had previously closed at $20.80.
Bone Biologics Price Performance
The business has a 50 day simple moving average of $40.38 and a two-hundred day simple moving average of $41.36.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Further Reading
- Five stocks we like better than Bone Biologics
- What Makes a Stock a Good Dividend Stock?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- 3 Tickers Leading a Meme Stock Revival
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What is Insider Trading? What You Can Learn from Insider Trading
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
